555
Participants
Start Date
April 30, 2014
Primary Completion Date
April 30, 2015
Study Completion Date
December 31, 2015
ABC/DTG/3TC FDC
Purple, oval, biconvex tablets containing 702 mg Abacavir sulphate which is equivalent to 600 mg ABC, 52.62 mg Dolutegravir sodium which is equivalent to 50 mg Dolutegravir free acid and 300 mg 3TC
Ongoing cART regimen
Stable cART regimens including boosted PI (or ATV unboosted) + 2 NRTIs; NNRTI + 2 NRTIs, or INI (RAL or EVG)+ 2 NRTIs
GSK Investigational Site, New York
GSK Investigational Site, The Bronx
GSK Investigational Site, Valhalla
GSK Investigational Site, Manhasset
GSK Investigational Site, Buffalo
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Allentown
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Annandale
GSK Investigational Site, Lynchburg
GSK Investigational Site, Greensboro
GSK Investigational Site, Charlotte
GSK Investigational Site, Charleston
GSK Investigational Site, Decatur
GSK Investigational Site, Atlanta
GSK Investigational Site, Atlanta
GSK Investigational Site, Atlanta
GSK Investigational Site, Savannah
GSK Investigational Site, Jacksonville
GSK Investigational Site, Pensacola
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Tampa
GSK Investigational Site, Ft. Pierce
GSK Investigational Site, Akron
GSK Investigational Site, Indianapolis
GSK Investigational Site, Berkley
GSK Investigational Site, Ann Arbor
GSK Investigational Site, Iowa City
GSK Investigational Site, Minneapolis
GSK Investigational Site, Minneapolis
GSK Investigational Site, Chicago
GSK Investigational Site, St Louis
GSK Investigational Site, St Louis
GSK Investigational Site, St Louis
GSK Investigational Site, Kansas City
GSK Investigational Site, New Orleans
GSK Investigational Site, Tulsa
GSK Investigational Site, Dallas
GSK Investigational Site, Dallas
GSK Investigational Site, Longview
GSK Investigational Site, Fort Worth
GSK Investigational Site, Houston
GSK Investigational Site, Bellaire
GSK Investigational Site, Austin
GSK Investigational Site, Denver
GSK Investigational Site, Phoenix
GSK Investigational Site, Phoenix
GSK Investigational Site, Santa Fe
GSK Investigational Site, Las Vegas
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Beverly Hills
GSK Investigational Site, Torrance
GSK Investigational Site, Long Beach
GSK Investigational Site, San Diego
GSK Investigational Site, Newport Beach
GSK Investigational Site, Bakersfield
GSK Investigational Site, San Francisco
GSK Investigational Site, San Francisco
GSK Investigational Site, San Francisco
GSK Investigational Site, San Leandro
GSK Investigational Site, Oakland
GSK Investigational Site, Sacramento
GSK Investigational Site, Honolulu
GSK Investigational Site, Seattle
GSK Investigational Site, Denver
GSK Investigational Site, Norwalk
GSK Investigational Site, Vero Beach
GSK Investigational Site, Augusta
GSK Investigational Site, Chicago
GSK Investigational Site, Springfield
GSK Investigational Site, Camden
GSK Investigational Site, Hillsborough
GSK Investigational Site, Newark
GSK Investigational Site, Cincinnati
GSK Investigational Site, Dallas
GSK Investigational Site, Calgary
GSK Investigational Site, Vancouver
GSK Investigational Site, Vancouver
GSK Investigational Site, Victoria
GSK Investigational Site, Winnipeg
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Ponce
GSK Investigational Site, Rio Piedras
GSK Investigational Site, San Juan
GSK Investigational Site, San Juan
Lead Sponsor
Collaborators (2)
PPD Development, LP
INDUSTRY
GlaxoSmithKline
INDUSTRY
ViiV Healthcare
INDUSTRY